DGAP-Adhoc: CTS EVENTIM posts substantial boost in revenue

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Feb 25, 2014 at 3:45 AM

DGAP-Adhoc: CTS EVENTIM posts substantial boost in revenue and earnings

CTS Eventim AG / Key word(s): Preliminary Results 25.02.2014 09:28 Dissemination of an Ad hoc announcement according to Â§ 15 WpHG, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Ad hoc Announcement pursuant to Section 15 WpHG (Securities Trading Act) Preliminary figures for the 2013 financial year (1.1. - 31.12.13) CTS EVENTIM posts substantial boost in revenue and earnings Group revenue up 20.8% to EUR 628.3 million / Normalised EBITDA advances 13.7% to EUR 136.3 million / Live Entertainment segment increases EBITDA by 16.2% to EUR 32.0 million / Ticketing segment improves normalised EBITDA by 12.4% to EUR 104.3 million Munich, 25 February 2014. CTS EVENTIM AG, listed in the SDAX index (ISIN DE0005470306), boosted revenue and earnings to record level in the 2013 financial year and continued to reinforce its leadership in the European ticketing and live events markets. Despite phases of economic weakness in some individual European countries, the business model of the CTS Group proved to be very robust. The two segments, Ticketing and Live Entertainment, achieved significant growth in both revenue and earnings. The Management Board will announce its dividend proposal for the past financial year when the Annual Report is published at the end of March 2014. According to preliminary figures, the CTS Group showed excellent business performance in the financial year 2013. Revenue rose 20.8% to EUR 628.3 million (2012: EUR 520.3 million), while normalised EBITDA improved by 13.7% to EUR 136.3 million (2012: EUR 119.9 million). Normalised EBIT, before amortisation from purchase price allocation, was up 15.4% year-on-year at EUR 123.7 million (2012: EUR 107.1 million). EBITDA rose 11.0% to EUR 133.9 million (2012: EUR 120.6 million), while EBIT improved by 13.4% to EUR 110.9 million (2012: EUR 97.8 million). In the period under review, the Ticketing segment generated EUR 269.7 million in revenue before consolidation between segments, up 16.5% from EUR 231.5 million in 2012. The Ticketing segment achieved a significant year-on-year increase in revenue and earnings due to many attractive events and the traditionally strong fourth quarter. In the financial year 2013, the CTS Group sold 23.8 million tickets via the Internet - which equates to around 16% growth over the prior year (20.6 million tickets). Normalised EBITDA was up 12.4% at EUR 104.3 million (2012: EUR 92.8 million), while normalised EBIT before amortisation from purchase price allocation was up 14.3% at EUR 93.9 million (2012: EUR 82.1 million). EBITDA was 9.0% higher at EUR 101.9 million (2012: EUR 93.5 million), while EBIT increased by 12.1% to EUR 81.6 million (2012: EUR 72.8 million). The Live Entertainment segment reported strong revenue growth of 23.4% to EUR 365.8 million in the year under review, compared to EUR 296.4 million in 2012. EBITDA was 16.2% higher at EUR 32.0 million (2012: EUR 27.5 million), while EBIT increased by 15.3% to EUR 29.3 million (2012: EUR 25.4 million). In this segment also, the large number of attractive live events was a key factor contributing to excellent business performance on record level. Following a strong performance in 2013 and a good start into the new financial year 2014, the Management Board expects positive business performance in 2014 as well. These expectations are further supported by the continuous expansion of Internet ticketing operations, by continuing international expansion and by the launching of new products and services by the CTS Group. The figures for 2012 have been adjusted due to application of mandatory accounting standards (amended IAS 19). For further information contact: Marco Haeckermann, Director Corp. Development & Strategy, CTS EVENTIM AG, + 49 421 3666 270 Volker Bischoff, CFO, CTS EVENTIM AG, +49 421 3666 250 25.02.2014 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: CTS Eventim AG Dingolfinger Str. 6 81673 MÃ¼nchen Germany Phone: 0421/ 3666-233 Fax: 0421/ 3666-290 E-mail: claudia.aderhold@eventim.de Internet: www.eventim.de ISIN: DE0005470306 WKN: 547030 Indices: SDAX Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, DÃ¼sseldorf, Hamburg, Hannover, MÃ¼nchen, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PenFed Credit Union's Soaring Loan Originations in Q3 2026

Staggering Growth in Loan Originations Ever wake up to an unexpected windfall? That's the kind of headline PenFed Credit Union is writing with its $8.8 billion in year-to-date loan originations by the end of September 2026. Up 22% year-over-year, folks. Those numbers don't just happen by accident. That's hitting the nail on the head in the credit union world. Mortgage and...

AstroRad Vest Makes Spaceflight History at Smithsonian

Space Gear Finds a New Home In a move that brings a piece of the cosmos down to Earth, the AstroRad radiation protection vest, used by astronauts aboard the International Space Station (ISS), has landed a spot in the Smithsonian's National Air and Space Museum. It's not just some random hunk of tech; this vest represents a milestone in the annals of space gear — a...

Cooper's Stock Takes a Beating: What's Behind It?

A Shock to the System: Cooper's Rough Patch Not every day you see a stock take a body slam like this! Cooper Companies (NASDAQ: COO) got walloped after revealing some unsavory truths about its Q3 2026 performance. The market didn't just flinch—it reeled. On September 10, 2026, COO shares dove a steep $9.31—around a 14.6% free fall—whacking off over $1.7 billion in...

Green Methanol: A $20.11B Market by 2032 Excites

The Green Methanol Boom Folks, the money's about to get greener—greener methanol, that is. We’re talking about a market that’s set to explode from a humble $3.46 billion in 2026 to a jaw-dropping $20.11 billion by 2032. With a hefty CAGR of 34.1%, it seems like investors might want to buckle up for a bullish ride in this eco-friendly venture. Why Green Methanol?...

Del Monte Faces Class Action Over Major Data Breach

Data Breach Fallout Looms Over Del Monte Here's the scoop on Del Monte Foods facing what looks like a data breach debacle of epic proportions. Ransomware has hit the fan, and now folks are scrambling as Edelson Lechtzin LLP gears up to lay down some serious class action heat. From Cyber Shadows to Court Considerations This storm brewed on February 7, 2026. Del Monte’s...

Cytrellis Boosts Aesthetics Training With Miami Partnership

Cytrellis Partners with University of Miami The announcement from Cytrellis Biosystems is drawing some attention. The company's jumped into a new partnership with the University of Miami School of Nursing and Health Studies, looking to jazz up their Aesthetic Medicine Certificate Program. The kicker here is the introduction of Cytrellis' ellacor® system, a fancy bit of...

BioArctic's Moves: Lecanemab Data and Leadership Insights

BioArctic's Power Play: A Two-Pronged Update Ever feel like biotechnology is just a series of chess moves? BioArctic's recent maneuvers in the life sciences game certainly hint at that. First, they've got data brewing on lecanemab—this ain't small beans, folks, not with Alzheimer's disease in the crosshairs. Then there's their Nomination Committee. It’s like shaking...

SCI Faces Investigation After Earnings Downgrade

SCI's Rough Ride: Investors Brace for Impact There's nothing like waking up to find the stock you were banking on took a nosedive while you were dreaming of dividends. Service Corporation International (NYSE: SCI) sure gave shareholders more of a nightmare than a dream, slashing its earnings forecast for 2026 and watching its stock crumble by about 11.6% on October 29....

Intestinal Worms: New Science and Old Challenges

Intestinal Worms: A Modern Twist on an Old Tale Just when you thought you'd heard it all, here comes the notion that intestinal worms might actually be good for us. The stuff of cringe-worthy junior high biology classes is now strutting its stuff in F1000Research. Sounds odd? Maybe, but there's a half-century of science behind it. Old Foes with New Friends These...

Gastops and Bell: A New Era in Aerospace Collaboration

Gastops and Bell Seal a Forward-Looking Deal Who would've thought Gastops and Bell, two juggernauts in their respective fields, would link arms to drive the aerospace game forward in Canada? That's right, a Memorandum of Understanding (MOU) was inked between these titans at the 2026 Canadian Aerospace Summit, paving the way for collaboration on future programs. This isn't...